C4 Therapeutics
CCCC
#8153
Rank
โ‚ฌ0.29 B
Marketcap
2,26ย โ‚ฌ
Share price
1.64%
Change (1 day)
6.71%
Change (1 year)

EPS for C4 Therapeutics (CCCC)

EPS in 2026 (TTM): -0,62ย โ‚ฌ

According to C4 Therapeutics's latest financial reports the company's current EPS (TTM) is -0,66ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,24ย โ‚ฌ an increase over its 2024 EPS that were of -1,38ย โ‚ฌ.

EPS history for C4 Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,62ย โ‚ฌ-49.59%
2025-1,24ย โ‚ฌ-9.93%
2024-1,38ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ 87.50%๐Ÿ‡บ๐Ÿ‡ธ USA